Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series
Clinical and Experimental Nephrology · 2025
DOI: 10.1007/s10157-024-02597-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Nephrology, 2025. Verfasst von Yoshifumi Ubara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan. ubara@toranomon.gr…. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Cysts, Liver Diseases, Polycystic Kidney, Autosomal Dominant. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
We have achieved good results of renal transarterial embolization (TAE) therapy as an alternative to surgical nephrectomy to decrease renal size in autosomal polycystic kidney disease (ADPKD) patients with enlarged kidneys, but only in patients on dialysis. Renal transplantation is another treatment option, and patients who receive a donor kidney have achieved a reduction in kidney size after surgery. TAE has also been used in polycystic liver disease (PCLD), an extrarenal lesion of ADPKD. Although TAE is effective in some PCLD patients, others develop hepatomegaly, which leads to liver cyst infection and liver failure. Recently, liver transplantation has started to be performed in such patients. Initially, living donor liver transplants were performed from family members, but in 2010, deceased donor liver transplantation became available. This article gives an overview of the history of TAE for ADPKD and PCLD on the basis of our experience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan. ubara@toranomon.gr.jp.
- Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan.
Zitieren
APA
Ubara, Y., Suwabe, T., & Sawa, N. (2025). Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02597-1
Vancouver
Ubara Y, Suwabe T, Sawa N. Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series. Clinical and Experimental Nephrology. 2025. doi:10.1007/s10157-024-02597-1
BibTeX
@article{Ubara2025,
author = {Ubara, Yoshifumi and Suwabe, Tatsuya and Sawa, Naoki},
title = {Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series},
journal = {Clinical and Experimental Nephrology},
year = {2025},
doi = {10.1007/s10157-024-02597-1}
}
EUVIMED